Progress and controversies in developing cancer vaccines

by Slingluff, Craig L, Speiser, Daniel E
Published 2005

TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling

by Mauldin, Ileana S, Slingluff, Craig L, Wang, Ena
Published 2014

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

by Molhoek, Kerrington R, Brautigan, David L, Slingluff, Craig L
Published 2005

TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines

by Mauldin, Ileana S, Wang, Ena, Deacon, Donna H, Slingluff, Craig L
Published 2013

Antibody response to melanoma helper-peptide vaccine correlates with survival

by Olson, Walter C, Reed, Caroline M, Slingluff, Craig L
Published 2013

Defining the effects of age and gender on clinical immune response to cancer vaccination

by Ramirez, Adriana, Wages, Nolan, Smolkin, Mark E, Slingluff, Craig L
Published 2014

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma

by Kaufman, Howard L, Ruby, Carl E, Hughes, Tasha, Slingluff, Craig L
Published 2014

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells

by Melssen, Marit M, Hutchison, Ciara, Mauldin, Ileana S, Bullock, Timothy N, Slingluff, Craig L
Published 2015

From bench to bedside a comprehensive review of pancreatic cancer immunotherapy

by Kunk, Paul R., Bauer, Todd W., Slingluff, Craig L., Rahma, Osama E.
Published 2016

Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma

by Benamar, Mouadh, Guessous, Fadila, Du, Kangping, Corbett, Patrick, Obeid, Joseph, Gioeli, Daniel, Slingluff, Craig L., Abbas, Tarek
Published 2016

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

by Reuss, Joshua E., Kunk, Paul R., Stowman, Anne M., Gru, Alejandro A., Slingluff, Craig L., Gaughan, Elizabeth M.
Published 2016

A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable...

by Katz, Matthew, Todd, Bauer W, Varadhachary, Gauri, Acquavella, Nicolas, Petroni, Gina, Bullock, Timothy, Slingluff, Craig L, Rahma, Osama
Published 2015

The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol

by Mosse, Claudio A., Meadows, Leslie, Luckey, Chance J., Kittlesen, David J., Huczko, Eric L., Slingluff, Craig L., Shabanowitz, Jeffrey, Hunt, Donald F., Engelhard, Victor H.
Published 1998

Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield,...

by Olson, Walter C, Smolkin, Mark E, Farris, Erin M, Fink, Robyn J, Czarkowski, Andrea R, Fink, Jonathan H, Chianese-Bullock, Kimberly A, Slingluff, Craig L
Published 2011

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes

by Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Published 2013

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

by Capaldo, Brian J., Roller, Devin, Axelrod, Mark J., Koeppel, Alex F., Petricoin, Emanuel F., Slingluff, Craig L., Weber, Michael J., Mackey, Aaron J., Gioeli, Daniel, Bekiranov, Stefan
Published 2015

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes

by Slingluff, Craig L, Petroni, Gina R, Olson, Walter C, Chianese-bullock, Kimberly A, Smith, Kelly T, Smolkin, Mark E, Galeassi, Nadedja, Grosh, William, Weiss, Geoffrey, Scott, Kristy, Hornillo, Ana
Published 2014

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes

by Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Published 2014

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

by Mauldin, Ileana S, Wages, Nolan A, Stowman, Anne M, Wang, Ena, Smolkin, Mark E, Olson, Walter C, Deacon, Donna H, Smith, Kelly T, Galeassi, Nadejda, Teague, Jessica E, Clark, Rachael A, Marincola, Francesco M, Petroni, Gina R, Mullins, David W, Slingluff, Craig L
Published 2015

Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology

by Tahara, Hideaki, Sato, Marimo, Thurin, Magdalena, Wang, Ena, Butterfield, Lisa H, Disis, Mary L, Fox, Bernard A, Lee, Peter P, Khleif, Samir N, Wigginton, Jon M, Ambs, Stefan, Akutsu, Yasunori, Chaussabel, Damien, Doki, Yuichiro, Eremin, Oleg, Fridman, Wolf Hervé, Hirohashi, Yoshihiko, Imai, Kohzoh, Jacobson, James, Jinushi, Masahisa, Kanamoto, Akira, Kashani-Sabet, Mohammed, Kato, Kazunori, Kawakami, Yutaka, Kirkwood, John M, Kleen, Thomas O, Lehmann, Paul V, Liotta, Lance, Lotze, Michael T, Maio, Michele, Malyguine, Anatoli, Masucci, Giuseppe, Matsubara, Hisahiro, Mayrand-Chung, Shawmarie, Nakamura, Kiminori, Nishikawa, Hiroyoshi, Palucka, A Karolina, Petricoin, Emanuel F, Pos, Zoltan, Ribas, Antoni, Rivoltini, Licia, Sato, Noriyuki, Shiku, Hiroshi, Slingluff, Craig L, Streicher, Howard, Stroncek, David F, Takeuchi, Hiroya, Toyota, Minoru, Wada, Hisashi, Wu, Xifeng, Wulfkuhle, Julia, Yaguchi, Tomonori, Zeskind, Benjamin, Zhao, Yingdong, Zocca, Mai-Britt, Marincola, Francesco M
Published 2009